HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $106,578 | +10.7% | 2,790 | +4.6% | 0.01% | +10.0% |
Q2 2023 | $96,235 | +143.7% | 2,668 | +158.0% | 0.01% | +150.0% |
Q1 2023 | $39,489 | -27.7% | 1,034 | +7.7% | 0.00% | -33.3% |
Q4 2022 | $54,624 | +203.5% | 960 | +111.5% | 0.01% | +200.0% |
Q3 2022 | $18,000 | -10.0% | 454 | +0.4% | 0.00% | -33.3% |
Q2 2022 | $20,000 | +42.9% | 452 | +25.9% | 0.00% | +50.0% |
Q1 2022 | $14,000 | +55.6% | 359 | +56.1% | 0.00% | +100.0% |
Q4 2021 | $9,000 | +50.0% | 230 | +46.5% | 0.00% | 0.0% |
Q3 2021 | $6,000 | 0.0% | 157 | +26.6% | 0.00% | 0.0% |
Q2 2021 | $6,000 | +20.0% | 124 | +2.5% | 0.00% | 0.0% |
Q1 2021 | $5,000 | 0.0% | 121 | +12.0% | 0.00% | 0.0% |
Q4 2020 | $5,000 | +66.7% | 108 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $3,000 | 0.0% | 108 | +14.9% | 0.00% | 0.0% |
Q2 2020 | $3,000 | -91.7% | 94 | -95.4% | 0.00% | -83.3% |
Q1 2020 | $36,000 | +2.9% | 2,053 | +0.5% | 0.01% | +50.0% |
Q4 2019 | $35,000 | +483.3% | 2,042 | +476.8% | 0.00% | 0.0% |
Q4 2015 | $6,000 | – | 354 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |